Biotheus Inc.: Clinical Trials

18 trials sponsored by Biotheus Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 active not recruiting, 6 unknown, 2 completed, 2 recruiting. 13 Phase 2, 9 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Active not recruiting 5, Unknown 3, Completed 2, Recruiting 2, Not yet recruiting 1
Phase 19Unknown 6, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 32Active not recruiting 2

Follow Biotheus Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
PM8002, Chemotherapy Regimen 1, Chemotherapy Regimen 2 - CRC (Colorectal Cancer)
Phase 2RecruitingBiotheus Inc.1002025-08-192026-07-23
A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC
PM8002, PM1009, atezolizumab - HCC, Liver Cancer
Phase 1 / Phase 2Not yet recruitingBiotheus Inc.1402024-12-012024-12-16
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
PM8002, Paclitaxel, Topotecan - SCLC
Phase 3Active not recruitingBiotheus Inc.4042024-11-132026-10-22
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
PM8002, Nab-Paclitaxel, Placebo - Triple Negative Breast Cancer(TNBC)
Phase 3Active not recruitingBiotheus Inc.3922024-06-112026-07-29
A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours
PM1021, PM8001 - Advanced Solid Tumours
Phase 1UnknownBiotheus Inc.302023-10-302023-02-08
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC
PM8002, Carboplatin, Pemetrexed - NSCLC
Phase 2Active not recruitingBiotheus Inc.642023-06-262025-04-03
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
PM8002, Platinum, Etoposide - SCLC
Phase 2Active not recruitingBiotheus Inc.502023-06-012025-03-12
A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
PM8002, FOLFIRI - Neuroendocrine Neoplasm
Phase 2Active not recruitingBiotheus Inc.312023-05-172026-07-09
A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours
PM1009 injection - Advanced Tumor
Phase 1UnknownBiotheus Inc.542022-11-212023-02-08
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
PM8002, Pemetrexed, Cisplatin - MPM
Phase 2CompletedBiotheus Inc.312022-08-132026-06-08
Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors
PM1032 injection - Advanced Tumor
Phase 1 / Phase 2UnknownBiotheus Inc.2002022-07-082023-05-06
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
PM8002, nab-paclitaxel - TNBC
Phase 1 / Phase 2Active not recruitingBiotheus Inc.422022-07-012025-03-11
A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC
PM8002, Paclitaxel - SCLC
Phase 2Active not recruitingBiotheus Inc.992022-05-272024-12-18
A Study of PM1015 in Patients With Advanced Solid Tumors
CD73 Antigen - Advanced Solid Tumor
Phase 1UnknownBiotheus Inc.202022-05-102023-07-18
PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma
PM8002, FOLFOX regimen - Hepatocellular Carcinoma
Phase 2CompletedBiotheus Inc.352022-04-222026-07-09
A Study of PM1022 in Patients With Advanced Tumors
PM1022 - Advanced Tumors
Phase 1 / Phase 2UnknownBiotheus Inc.2002022-04-112023-05-22
Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors
PM1003 Injection - Advanced Solid Tumors
Phase 1 / Phase 2UnknownBiotheus Inc.2852021-09-072023-05-17
PM8002 in the Treatment of Patients With Advanced Solid Tumors
PM8002 - Malignant Neoplasm
Phase 1 / Phase 2RecruitingBiotheus Inc.3802021-03-092024-12-05

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)  ·  Neuroendocrine Tumors (1)  ·  Triple Negative Breast Neoplasms (1)

Interventions

130-nm albumin-bound paclitaxel (2)  ·  Carboplatin (2)  ·  Paclitaxel (2)  ·  Pemetrexed (2)  ·  5'-Nucleotidase (1)  ·  Bevacizumab (1)  ·  Cisplatin (1)  ·  Etoposide (1)  ·  Folfox protocol (1)  ·  IFL protocol (1)  ·  Platinum (1)  ·  Topotecan (1)  ·  atezolizumab (1)

Countries

China (16)

Top investigators

Ye Guo (5)  ·  Haifeng Liu (2)  ·  Ying Cheng (2)  ·  Caicun Zhou (1)  ·  Jia Fan (1)  ·  Jian Zhang, professor (1)  ·  Jianming Xu (1)  ·  Jieer Ying (1)  ·  Jiong Wu, professor (1)  ·  Lin Shen, PhD (1)  ·  Ruihua Xu, PhD, MD (1)  ·  Vineet Kwatra (1)  ·  Wu Jiong (1)  ·  Wu Yilong, PhD (1)